🇺🇸 FDA
Patent

US 12006517

Method for purification of bacteriophage particles

granted A61KA61K35/76A61P

Quick answer

US patent 12006517 (Method for purification of bacteriophage particles) held by Adaptive Phage Therapeutics, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Adaptive Phage Therapeutics, Inc.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K35/76, A61P, A61P31/04